The efficacy of an anti-CD4 monoclonal antibody for HIV-1 treatment-Reference-Cited by-同舟云学术

The efficacy of an anti-CD4 monoclonal antibody for HIV-1 treatment

Published:2011-12 Issue:3 Volume:92 Page:484-487
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Fessel W. Jeffrey,Anderson Brooke,Follansbee Stephen E.,Winters Mark A.,Lewis Stanley T.,Weinheimer Steven P.,Petropoulos Christos J.,Shafer Robert W.

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference13 articles.

1. Development of anti-CD4 MAb hu5A8 for treatment of HIV-1 infection: preclinical assessment in non-human primates;Boon;Toxicology,2002

2. Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion;Burkly;J. Immunol.,1992

3. Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibody;Freeman;Structure,2010

4. Antibodies for HIV treatment and prevention: window of opportunity?;Huber;Curr. Top. Microbiol. Immunol.,2008

5. Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adults;Jacobson;Antimicrob. Agents Chemother.,2009

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ex vivo sensitivity to broadly neutralizing antibodies and anti-CD4 antibody UB-421 of infectious viral isolates from people living with multidrug-resistant HIV;eBioMedicine;2024-06

2. Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-05

3. The Phenomenon of Antiretroviral Drug Resistance in the Context of Human Immunodeficiency Virus Treatment: Dynamic and Ever Evolving Subject Matter;Biomedicines;2024-04-20

4. Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review;Viruses;2023-08-13

5. Design of a Bispecific HIV Entry Inhibitor Targeting the Cell Receptor CD4 and Viral Fusion Protein Gp41;Frontiers in Cellular and Infection Microbiology;2022-05-27